JP2014520075A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520075A5 JP2014520075A5 JP2014509829A JP2014509829A JP2014520075A5 JP 2014520075 A5 JP2014520075 A5 JP 2014520075A5 JP 2014509829 A JP2014509829 A JP 2014509829A JP 2014509829 A JP2014509829 A JP 2014509829A JP 2014520075 A5 JP2014520075 A5 JP 2014520075A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- salt
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1107985.2A GB201107985D0 (en) | 2011-05-13 | 2011-05-13 | Process |
| GB1107985.2 | 2011-05-13 | ||
| PCT/GB2012/051037 WO2012156693A1 (en) | 2011-05-13 | 2012-05-11 | Process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014520075A JP2014520075A (ja) | 2014-08-21 |
| JP2014520075A5 true JP2014520075A5 (enExample) | 2015-07-02 |
Family
ID=44260448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014509829A Withdrawn JP2014520075A (ja) | 2011-05-13 | 2012-05-11 | 方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20140364601A1 (enExample) |
| EP (1) | EP2707362A1 (enExample) |
| JP (1) | JP2014520075A (enExample) |
| KR (1) | KR20140045380A (enExample) |
| CN (1) | CN103649060A (enExample) |
| AU (1) | AU2012257630A1 (enExample) |
| BR (1) | BR112013028789A2 (enExample) |
| CA (1) | CA2835237A1 (enExample) |
| GB (1) | GB201107985D0 (enExample) |
| IL (1) | IL229126A0 (enExample) |
| MX (1) | MX2013012484A (enExample) |
| RU (1) | RU2013148907A (enExample) |
| SG (1) | SG194631A1 (enExample) |
| WO (1) | WO2012156693A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3192B1 (ar) | 2011-09-06 | 2018-03-08 | Novartis Ag | مركب بنزوثيازولون |
| CN103193658A (zh) * | 2013-04-18 | 2013-07-10 | 苏州永健生物医药有限公司 | 一种（r）-2-对硝基苯乙胺基-1-苯乙醇及其盐的合成方法 |
| TWI685497B (zh) | 2014-06-02 | 2020-02-21 | 西班牙商伊史帝夫製藥公司 | 具有多重模式抗疼痛活性的１-氧雜-４,９-二氮雜螺十一烷化合物之烷基衍生物 |
| TW201615642A (zh) * | 2014-06-02 | 2016-05-01 | 伊史帝夫博士實驗室股份有限公司 | 具有多重模式抗疼痛活性的１－氧雜－４，９－二氮雜螺十一烷化合物之醯胺衍生物 |
| US10927128B2 (en) | 2015-11-16 | 2021-02-23 | Esteve Pharmaceuticals. S.A. | Oxadiazaspiro compounds for the treatment of drug abuse and addiction |
| PT3697795T (pt) | 2017-10-17 | 2024-02-29 | Acondicionamiento Tarrasense | Sais de (r)-9-(2,5-difluorofenetil)-4-etil-2-metil-1-oxa-4,9-diazaespiro[5.5]undecan-3-ona |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3283032B2 (ja) | 1998-02-02 | 2002-05-20 | エルジ ケミカル リミテッド | ピペリジン構造を有するファネシル転移酵素阻害剤及びその製造方法 |
| PE20050130A1 (es) | 2002-08-09 | 2005-03-29 | Novartis Ag | Compuestos organicos |
| GB0218629D0 (en) * | 2002-08-09 | 2002-09-18 | Novartis Ag | Organic compounds |
| TW200738659A (en) | 2005-08-29 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
| CN101300239A (zh) * | 2005-08-29 | 2008-11-05 | 阿斯利康(瑞典)有限公司 | 作为β2肾上腺素受体激动剂的7-（2-氨基-1-羟基-乙基）-4-羟基苯并噻唑-2(3H)-酮衍生物 |
| PT2242759E (pt) * | 2008-02-06 | 2012-12-17 | Astrazeneca Ab | Compostos |
-
2011
- 2011-05-13 GB GBGB1107985.2A patent/GB201107985D0/en not_active Ceased
-
2012
- 2012-05-11 US US14/117,259 patent/US20140364601A1/en not_active Abandoned
- 2012-05-11 EP EP12722808.8A patent/EP2707362A1/en not_active Withdrawn
- 2012-05-11 BR BR112013028789A patent/BR112013028789A2/pt not_active IP Right Cessation
- 2012-05-11 WO PCT/GB2012/051037 patent/WO2012156693A1/en not_active Ceased
- 2012-05-11 CN CN201280034581.XA patent/CN103649060A/zh active Pending
- 2012-05-11 JP JP2014509829A patent/JP2014520075A/ja not_active Withdrawn
- 2012-05-11 SG SG2013079363A patent/SG194631A1/en unknown
- 2012-05-11 RU RU2013148907/04A patent/RU2013148907A/ru not_active Application Discontinuation
- 2012-05-11 KR KR1020137032749A patent/KR20140045380A/ko not_active Withdrawn
- 2012-05-11 CA CA2835237A patent/CA2835237A1/en not_active Abandoned
- 2012-05-11 AU AU2012257630A patent/AU2012257630A1/en not_active Abandoned
- 2012-05-11 MX MX2013012484A patent/MX2013012484A/es not_active Application Discontinuation
-
2013
- 2013-10-28 IL IL229126A patent/IL229126A0/en unknown
-
2015
- 2015-09-17 US US14/857,254 patent/US20160002261A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014520075A5 (enExample) | ||
| Bruno et al. | Design and preparation of new palladium precatalysts for C–C and C–N cross-coupling reactions | |
| JP2013518910A5 (enExample) | ||
| AU2014220735B2 (en) | Vortioxetine manufacturing process | |
| JP2009235096A5 (enExample) | ||
| JP2015507023A5 (enExample) | ||
| Luo et al. | Asymmetric ring-opening of oxabenzonorbornadiene with amines promoted by a chiral iridium-monophosphine catalyst | |
| JP2007260659A5 (ja) | 液相反応用のポリシラン担持遷移金属触媒 | |
| CN102241566B (zh) | 一种二苯甲醇及其衍生物的制备方法 | |
| JP2013234194A5 (enExample) | ||
| WO2012164242A8 (en) | Process for the preparation of paliperidone | |
| CN101928222A (zh) | 一种n,n,n’,n’-四异丙基乙二胺的合成方法 | |
| JP2010132661A5 (enExample) | ||
| CN103157513A (zh) | 一种铝络合共轭微孔高分子催化剂及其制备和应用 | |
| CN102942500B (zh) | 一种n-甲酰胺类化合物的制备方法 | |
| JP2015508069A5 (enExample) | ||
| CN103214407B (zh) | 制备四氢吡咯类衍生物的方法 | |
| CN103450161A (zh) | 一种化合物zhangshuhua2及原位合成方法 | |
| JP2007045816A5 (ja) | カルバゾール誘導体、発光素子用材料として用いられるアントラセン誘導体の作製方法 | |
| CN108948055A (zh) | 一种8-甲基喹啉偕二硼化合物及其制备方法 | |
| CN104327106B (zh) | 高位阻芳基硼酸酯类化合物的制备方法 | |
| CN103804342A (zh) | 一种胡椒乙酸的制备方法 | |
| JP2015524456A5 (enExample) | ||
| CN103420857A (zh) | 一种具有金刚烷基的季铵盐的制备方法 | |
| CN103435506A (zh) | 一种具有金刚烷基的季铵盐的制备方法 |